State regulators and legislatures are considering new requirements for controlled substance prescribing and reporting.
Shannon L. Wiley, Mitchell James
Advertisement
Articles by Shannon L. Wiley, Mitchell James
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Closing the Kidney Gap in Cardio-Kidney-Metabolic Care
2
GLP-1 RAs Linked to Lower Mortality, Amputation Risk in Patients With PAD and Type 2 Diabetes
3
Pharmacists Can Catch Missed CKD With One Question
4
Pharmacists Can Help Patients Navigate GLP-1 Access, Affordability, and Long-Term Use
5